Smaller-scale trades involved Pacific Biosciences of California Inc (NASDAQ: PACB) and 10X Genomics Inc (NASDAQ: TXG ), with ARK purchasing 194,298 and 18,177 shares respectively, totaling $213,727 ...

Tempus AI reassured investors that its major pharma contracts remain strong despite funding and tariff pressures.

On Tuesday, Cathie Wood ‘s Ark Invest made significant trades, notably selling shares of Palantir Technologies Inc. PLTR ...

In 2014 Robin Greenwood and Andrei Shleifer, both of Harvard University, found that investors did not expect higher returns ...

Discussing Advanced Micro Devices, Inc. (AMD) stock on Schwab Network recently, Ryan Patel said that “if you believe in a ...

ARK Invest’s Cathie Wood says markets are shaking off major headwinds and may be primed for upside surprises—while warning ...

Shares of CRISPR Therapeutics (NASDAQ:CRSP) can’t seem to catch a break, now down close to 8% year to date and more than 80% ...

ARK Invest CEO Cathie Wood says that financial markets are likely setting up for surprises to the upside amid a shift in the macro landscape.

Cathie Wood, chief of Ark Investment Management, is best known for trading high-growth tech names. But this week, she took an ...

Can ARKK rebound from its steep decline, or just mirror market trends? Read our insight on its potential to deliver alpha ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...

Cathie Wood, head of Ark Investment Management, frequently adjusts her top positions, adding to a holding when the stock ...